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Introduction
Autophagy literally means ‘self-eating’ and is a major catabolic 
process within the cell.1 Three types of autophagy have been 
described: macroautophagy, microautophagy and chaperone-
mediated autophagy.2 Macroautophagy, which we will simply 
refer to here as autophagy, is the best characterized and is con-
sidered to operate in all cells. The process begins with the forma-
tion of a membranous structure called a phagophore or isolation 
membrane.3-5 The membrane grows to form a spherical organ-
elle termed an autophagosome which encapsulates cytoplasmic 
constituents.3-5 Autophagosomes can then undergo fusion events 
with other organelles such as endosomes and multivesicular bod-
ies, but ultimately fusion occurs with lysosomes forming a new 
organelle termed an autolysosome.3-5 The hydrolases provided by 
the lysosome degrade the cargo of the autophagosome and these 
are then delivered back into the cytoplasm where they are either 
further catabolized or recycled in biosynthetic pathways.
At basal levels autophagy serves as a mechanism to degrade 
misfolded and damaged proteins and it is the only mechanism 
within the cell for the degradation of whole organelles.2 In 
response to various stimuli, the levels and cargoes of autophagy 
can change to bring about desired effects within the cell. In this 
regard, autophagy is known to act as a protective mechanism 
within cells that acts to prevent various forms of human disease.2 
(Macro)autophagy is a membrane-trafficking process that serves to sequester cellular constituents in organelles termed 
autophagosomes, which target their degradation in the lysosome. Autophagy operates at basal levels in all cells where 
it serves as a homeostatic mechanism to maintain cellular integrity. the levels and cargoes of autophagy can, however, 
change in response to a variety of stimuli, and perturbations in autophagy are known to be involved in the etiology of 
various human diseases. Autophagy must therefore be tightly controlled. We report here that the Drosophila cyclin-
dependent kinase PITSLRE is a modulator of autophagy. Loss of the human PITSLRE ortholog, CDK11, initially appears 
to induce autophagy, but at later time points CDK11 is critically required for autophagic flux and cargo digestion. since 
PITSLRE/CDK11 regulates autophagy in both Drosophila and human cells, this kinase represents a novel phylogenetically 
conserved component of the autophagy machinery.
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Perturbations in autophagy control are known to contribute to 
cancer and inflammatory conditions such as Crohn disease.4,6-9 
Autophagy is also known to be critically required for the removal 
of protein aggregates that form in neurodegenerative disease, 
and autophagy is central for the correct functioning of both 
the innate and acquired immune responses.10,11 In light of these 
important and yet disparate roles of autophagy, it is critical that 
we understand the cellular factors required for autophagy and 
how the autophagic process is controlled.
A major mechanism involved in the control of protein func-
tion is phosphorylation. There are 518 kinases in human cells, 
which mediate phosphorylation events that control a multitude 
of processes within the cell by regulating protein function, pro-
tein folding, protein interaction and protein stability. Using a 
kinome-wide screen in Drosophila cells, we identify the cyclin-
dependent kinase, PITSLRE and its human ortholog CDK11 as 
critical regulators of basal autophagy. CDK11 was first identi-
fied as a cell division control (CDC)-related kinase belonging 
to the p34cdc2 family.12 CDK11 is the product of two duplicated 
genes, CDK11A and CDK11B (formerly named as CDC2L1 and 
CDC2L2).13 Subsequent studies on PITSLRE/CDK11 have 
revealed diverse roles for the kinase in controlling RNA splicing, 
apoptosis, sister chromatid adhesion and cytokinesis.14-19 We add 
to these roles by showing that CDK11 is a fundamental regula-
tor of autophagy. We show that while CDK11 appears to act as a 
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turnover. This revealed, as would be expected, 
that autophagosomes accumulate over time in 
the presence of Bafilomycin A1 because they 
cannot be turned over in the absence of lyso-
some function (Fig. S1).
Having validated the system, the S2R+ 
GFP-LC3 cells were then challenged under 
normal growth conditions with a previously 
described Drosophila kinome RNAi library 
and cells were visualized by fluorescence 
microscopy for the accumulation of GFP-LC3 
puncta.20 This approach could potentially 
reveal kinases which block induction of auto-
phagy or identify kinases which are required 
for turnover of autophagosomes (Fig. 1A). One 
kinase which when depleted by RNAi caused 
a particularly marked increase in GFP-LC3 
puncta, was the cyclin-dependent kinase 
PITSLRE (Fig. 1B). In order to confirm the 
results of the screen, and to rule out the pos-
sibility of an off-target effect of the RNAi, a 
second double-stranded RNA (dsRNA) duplex 
targeting a different region of PITSLRE was 
used. Knockdown of PITSLRE with this 
dsRNA also caused a marked accumulation of 
autophagosomes, confirming the initial results 
from the screen (Fig. 1B). No effect on auto-
phagosome accumulation was observed when 
cells were treated with a nontargeting dsRNA 
as control (Fig. 1B).
The human PITSLRE ortholog CDK11 is a modulator of 
autophagy. Phylogenetic analyses revealed that PITSLRE has 
one ortholog in human cells termed CDK11 which lies within 
the CMGC (cyclin-dependent kinases (CDKs), mitogen-
activated protein kinases (MAP kinases), glycogen synthase 
kinases (GSK) and CDK-like kinases) group of kinases (Fig. 
2A). CDK11 is encoded by two duplicated genes, CDK11A and 
CDK11B. Therefore we wanted to determine if human CDK11 
was also involved in the modulation of autophagy. To this end, 
HeLa and MDA-MB-231 cells expressing GFP-LC3 were chal-
lenged with two siRNAs to knockdown CDK11 and two non-
targeting siRNAs as controls. Both CDK11 siRNAs were able to 
significantly reduce CDK11 protein levels (Fig. 2B) and, similar 
to the result observed in the S2R+ cells, this caused a considerable 
increase in GFP-LC3 puncta indicating accumulation of auto-
phagosomes (Fig. 2C). No increase in autophagosome accumula-
tion was observed in cells treated with nontargeting siRNAs as 
controls (Fig. 2C). Quantification of the number of cells exhibit-
ing an increase in autophagosomes revealed that autophagy was 
clearly affected in 60–70% of the MDA-MB-231 and HeLa cell 
populations following CDK11 knockdown (Fig. 2D).
CDK11 regulates autophagic flux. Since autophagosomes 
are normally a transient mid-point in the complete autophagy 
process, their appearance can represent either an increase in auto-
phagosome formation or a block to their turnover—as is seen 
following treatment with bafilomycin A1 (Fig. S1). In order 
repressor of autophagy in cells grown under nutrient-rich condi-
tions, prolonged loss of CDK11 results in the accumulation of 
immature autophagic intermediates and inhibits autophagic flux.
Results
PITSLRE is a modulator of autophagy. In order to identify 
novel regulators of autophagy, we embarked on an RNA interfer-
ence (RNAi) kinome screen in Drosophila S2R+ cells. Drosophila 
cells were chosen for the screen due to the lower levels of func-
tional redundancy compared with mammalian systems, and also 
for the ease with which human orthologs of Drosophila kinases 
can be identified. An S2R+ cell line was therefore generated 
which expresses a GFP-LC3 transgene (GFP fused to Drosophila 
Atg8a).20 LC3 is an integral component of the autophagosome 
membrane. In cells with basal autophagy, the majority of LC3 is 
in a form called LC3-I which is diffuse within the cytoplasm.21,22 
Upon induction of autophagy, LC3 becomes cleaved and lipi-
dated and integrates into autophagosome membranes—as a form 
of LC3 termed LC3-II.21,22 With the GFP-LC3 transgene, this 
event can easily be detected by fluorescence microscopy as the 
appearance of distinct GFP puncta within the cell. To validate 
whether the system can detect changes in autophagosome num-
ber, we incubated Drosophila S2R+ GFP-LC3 cells with the lyso-
somotropic agent Bafilomycin A1. This agent is a potent inhibitor 
of lysosomal acidification and therefore blocks autophagosome 
Figure 1. the Drosophila kinase pitsLre is a modulator of autophagy. (A) schematic 
diagram showing the screen for kinase regulators of autophagy. Drosophila s2r+ Gfp-Lc3 
cells growing in nutrient-rich conditions were transfected with the Drosophila kinome rNAi 
libary. this screen theoretically allows for the identification of kinases that positively and 
negatively regulate Gfp-Lc3 puncta. (B) Drosophila s2r+ Gfp-Lc3 cells were transfected with 
indicated dsrNA sequences, as described in Materials and Methods, and images of Gfp-Lc3 
distribution obtained by confocal microscopy after a 72 h incubation period.
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clear that the cell cannot cope with this increased induction of 
autophagosome accumulation in the absence of CDK11 and 
as a result autophagosomal turnover and therefore completion 
of autophagy is significantly retarded although not completely 
blocked (Fig. 3A and B).
In order to further assess whether successful autophagy was 
indeed blocked following prolonged CDK11 knockdown, we 
assayed autophagic flux by analyzing cargo entrapment. p62/
SQSTM1 is an adaptor protein for autophagic cargo recruitment 
and is degraded by autophagy in multiple settings. Consistent 
with our analysis of LC3-I to LC3-II conversion, p62 protein 
levels initially decrease following CDK11 knockdown indicat-
ing that loss of CDK11 at early time points causes an increase 
in autophagic flux (Fig. 3A). The protease inhibitors E64d/
Pepstatin A, through inhibition of autophagosome turnover, are 
known to cause an accumulation of p62 as a result of impeded 
digestion of p62 within autolysosomes. If CDK11 is required for 
autophagosome turnover at later time points, treatment of cells 
with E64d/Pepstatin A should have no effect on p62 levels in 
cells where CDK11 has been knocked down by RNAi. Indeed, 
after 72 and 96 h we observed that E64d/Pepstatin A markedly 
increased p62 protein levels in cells treated with a nontarget-
ing siRNA control, whereas no induction of p62 was seen as a 
result of E64d/Pepstatin A treatment in cells where CDK11 was 
to determine which of these possibilities was causing auto-
phagosome accumulation following CDK11 knockdown, assays 
were undertaken to measure autophagic flux. In the first assay, we 
monitored the accumulation of LC3-II levels by protein gel blot-
ting following CDK11 knockdown either in the absence or pres-
ence of the lysosomal protease inhibitors, E64d and Pepstatin A. 
In the presence of these inhibitors, knockdown of an inhibitor of 
autophagy induction will cause a greater accumulation of LC3-II 
than occurs following treatment with E64d and Pepstatin A alone 
(more induction caused greater accumulation).22 Conversely, 
knockdown of a factor required for autophagosome turnover will, 
by contrast, have a limited effect on LC3-II accumulation if auto-
phagosome turnover is already impeded by E64d and Pepstatin 
A.22 Our initial results at early time points revealed that knock-
down of CDK11 in the presence of E64d/Pepstatin A caused 
enhanced LC3-II protein levels when compared with cells treated 
with E64d/Pepstatin A and a nontargeting siRNA control, indi-
cating that CDK11 knockdown was inducing autophagy (Fig. 
3A). At later time points, however, the combination of E64d/
Pepstatin A with CDK11 knockdown only had a limited effect 
on LC3-II levels when compared with cells treated with E64d/
Pepstatin A and a nontargeting siRNA control (Fig. 3A and B). 
We considered that the initial loss of CDK11 results in a cellular 
response to induce autophagy, but after longer periods it becomes 
Figure 2. the human ortholog of pitsLre, cDK11, is a regulator of autophagy. (A) sequence alignment of Drosophila kinases with human kinases 
demonstrates that the nearest ortholog of PITSLRE is CDK11. (B and c) MDA-MB-231 Gfp-Lc3 cells were transfected with nontargeting control (Ntc) or 
cDK11 sirNAs for 72 h and (B) protein samples immunoblotted with antibodies shown or (c) images captured by fluorescence microscopy. (D) MDA-
MB-231 and HeLa Gfp-Lc3 cells were treated as described in (B and c) and images quantified for cells with overt Gfp-Lc3 puncta (*p < 0.05 for both 
cDK11 knockdowns in each cell line).
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later time points it is clear that autophagosome turnover is signifi-
cantly retarded, although not completely blocked. How then can 
we explain these different effects on autophagy at different times? 
As no substrates of PITSLRE are currently known, it is only pos-
sible to speculate as to the role played by PITSLRE/CDK11 
in autophagy and how it can have different effects at different 
times. One possibility is that at early time points the depletion of 
CDK11 results in induction of autophagy, but at later time points 
loss of CDK11 also results in a decrease in lysosomal function. 
This potential explanation is consistent with the data we provide 
showing that while at later time points autolysosomes are clearly 
formed, their turnover is markedly reduced (Fig. 4).
One interesting observation from our studies is the downregu-
lation of p62 mRNA following protracted CDK11 knockdown 
(Fig. S2). We can only assume that p62 mRNA levels decrease fol-
lowing CDK11 knockdown through a mechanism that decreases 
either p62 transcription or p62 mRNA stability. Previous stud-
ies have shown that p62 protein levels feed-forward to regulate 
p62 transcription via the transcription factor NRF2.23 Following 
prolonged CDK11 knockdown, p62 may become sequestered 
in autophagosomes/autolysosomes which are retarded in their 
turnover. As a result, this may well break the feed-forward loop 
regulating p62 transcription leading to decreased levels of p62 
mRNA. Further studies are therefore required to ascertain if this 
mechanism is the cause of p62 mRNA downregulation following 
long-term loss of CDK11.
Although no clear mechanistic functions for CDK11 are 
known, in terms of targets for phosphorylation, the kinase has been 
reported to have effects on multiple biological functions includ-
ing apoptosis, RNA splicing and mitosis.14-19 It is important there-
fore not to simply focus on how CDK11 regulates components 
of the autophagy machinery to bring about the effects we report 
knocked down by siRNA (Fig. 3A). In addition, it was observed 
that p62 protein levels were lower in CDK11 knockdown cells 
compared with nontargeting controls. This can be explained by 
our observation that p62 mRNA levels are reduced following 
CDK11 knockdown (Fig. S2).
A block in the turnover of LC3-II and p62 levels as assessed 
by protein gel blotting does not discern whether the effects of 
CDK11 knockdown are through inhibition of fusion of auto-
phagosomes with lysosomes, or due to inhibition of turnover sub-
sequent to autophagosome/lysosome fusion. To address this issue 
and to assess for fusion between autophagosomes and lysosomes, 
we infected cells with an adenovirus expressing mCherry-LC3 
and stained for the lysosomal membrane protein LAMP2. This 
revealed that fusion between autophagosomes and lysosomes 
could easily be detected in cells following CDK11 knockdown 
indicating that while prolonged CDK11 knockdown impedes 
the turnover stage of autophagy, it does not do this by blocking 
autophagosome/lysosome fusion (Fig. 4). When taken together 
our data show that, while CDK11 may repress basal autophagy, 
prolonged CDK11 inhibition results in inhibition of successful 
autophagy.
Discussion
We report here for the first time that the cyclin-dependent kinase 
PITSLRE/CDK11 is a new factor regulating autophagy. We show 
that depletion of PITSLRE in Drosophila cells and CDK11, the 
one ortholog of PITSLRE in human cells, both result in accu-
mulation of autophagosomes indicating that the modulation of 
autophagy by the kinase is evolutionarily conserved. We also 
show in human cells that the initial depletion of CDK11 causes 
cells to undergo an initial induction of autophagic flux whereas at 
Figure 3. cDK11 regulates autophagic flux. (A) MDA-MB-231 cells were transfected with nontargeting control (Ntc1) or cDK11si1 sirNA for either 48, 
72 or 96 h and then treated with vehicle control or 10 μg/ml e64d/pepstatin A for 16 h. Lysates were immunoblotted for the indicated proteins.  
(B) Quantification of Lc3-ii levels following 96 h of cDK11 knockdown. Blots were probed using an anti-Lc3B antibody and the relevant Alexa-fluor 
680 secondary antibody. Lc3-ii bands were detected by Li-cor odyssey infrared scanning and normalized to erK2. Data are shown as mean Lc3-ii 
levels ± seM (n = 5). A two-tailed, paired student’s t-test was used to determine the statistical significance of Lc3-ii upregulation following e64d/ 
pepstatin A treatment between Ntc1 and cDK11si1 transfected cells (p = 0.001).
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Schneider’s medium. MDA-MB-231 and HeLa cells were 
cultured in DMEM (Gibco, 21969) + 10% FCS (Hyclone, 
SH30080.03), supplemented with antibiotics. Mammalian cell 
lines were authenticated by microsatellite genotyping. Stable 
expression of GFP-LC3 was achieved with pBabe-puro GFP-LC3 
retroviral vector.20 E64d (330005) and Pepstatin A (516481) were 
purchased from Calbiochem.
RNA interference. Drosophila cells were transfected with 
double-stranded RNA as previously described in reference 20. 
dsRNA sequences used were derived with T7-binding sequence 
tagged primers, followed by in vitro transcription with T7 poly-
merase. Gene-specific sequences of primers were: nontargeting 
control: 5' GCC AAA AAC ATA AAG AAA GGG CCC G and 
3' CCC TGG TAA TCC GTT TTA GAA TCC, PITSLRE 
1: ATG ACG ATG AGG AAA GCG AGG AGA G and CGG 
GAT AAT AGT TGG GCA GGG GAA T, PITSLRE 2: CTC 
CGA ACG AGA AGA TCT GG and CCC AAT TGC TTT 
GTA TGG CT. For mammalian cells, siRNAs used were NTC1 
(Dharmacon, D-001210-01), NTC2 (Dharmacon, D-001210-
02), CDK11si1 (Targeting sequence: CAA GAT CTA CAT 
CGT GAT GAA; Qiagen, S100287700) and CDK11si2 
(Targeting sequence: ATG GAG TGG TCT ACA GAG CAA; 
Qiagen, S103050978). Cells plated in 6 well plates were trans-
fected with Oligofectamine (Invitrogen, 12252-011) according 
to the manufacturer’s instructions, using 10 nM oligonucleotide 
concentration.
Protein gel blotting. Samples for analysis were obtained by 
direct lysis in lysis buffer (50 mM Hepes, 150 mM NaCl, 100 
mM NaF, 10 mM EDTA, 10 mM sodium pyrophosphate, prote-
ase inhibitors, 1% (v/v) Triton X-100, 0.1% (v/v) SDS). Protein 
here, but also how the effects of CDK11 on autophagy impinge 
on these other CDK11 functions and vice versa. In this regard, 
we examined the effects of CDK11 knockdown on cell cycle 
progression and cell death in MDA-MB-231 cells. This revealed 
that in the time frame studied, CDK11 knockdown had no effect 
on apoptosis as assessed by analysis for sub-G
1
 DNA content—a 
reliable marker of apoptotic death (Fig. S3).24 Moreover, accu-
mulation of autophagosomes following CDK11 knockdown was 
not inhibited with a concentration of the pan-caspase inhibitor, 
zVAD-fmk that was sufficient to inhibit TNFα-driven apoptotic 
cell death (Fig. S4A and B). A small increase (15%) in cells in 
G
2
/M phase was observed following 72 h of CDK11 knockdown 
(Fig. S3), but we do not consider this to be the cause of auto-
phagy inhibition, since 70–80% of the cells exhibited marked 
autophagosome accumulation at this time point (Fig. 2D).
CDK11 has been reported to be perturbed in various human 
cancers including neuroblastoma, non-Hodgkin’s lymphoma and 
melanoma.25-27 In light of the findings we report here, it is natural 
to consider whether the regulation of autophagy is the reason for 
selection for alterations in CDK11 in these forms of cancer or again 
whether the involvement of CDK11 in other cellular functions is 
more important. Ultimately, extensive further studies are required 
to not only determine the role of CDK11 in the regulation of auto-
phagy, but also to ascertain if CDK11 represents another control 
point at which autophagy can be deregulated in human disease.
Materials and Methods
Cell culture and reagents. GFP-LC3 Drosophila cells are 
described in Wilkinson et al. 200920 and were cultured in 
Figure 4. cDK11 does not inhibit autophagosome and lysosome fusion. MDA-MB-231 cells expressing mcherry-Lc3 were transfected with nontarget-
ing control (Ntc1) or cDK11si1 sirNA for 72 h. As a control, Ntc1 transfected cells were also treated with vehicle control or 10 μg/ml e64d/pepstatin A 
for 16 h, and starved by incubation in eBss for the remaining 6 h. following fixation and permeabilization, cells were stained with a LAMp2 antibody 
and imaged by confocal microscopy. Arrows indicate co-localization of mcherry-Lc3 with LAMp2 in autolysosomes.
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Cell cycle analysis. Total populations of cells were harvested, 
and then fixed and permeabilized in 100% ice-cold methanol. 
PI staining was performed by incubation with propidium iodide 
(50 μg/ml) plus RNase A (125 μg/ml) for 45 min at room 
temperature. Flow cytometric analysis was performed using a 
FACSCalibur flow cytometer (Becton Dickinson) and CellQuest 
software.
qPCR analysis. RNA was prepared using an RNeasy Mini 
kit (Qiagen, 74104). cDNA was synthesized and qPCR per-
formed using the DyNAmo SYBR Green 2-step qRT-PCR kit 
(Finnzymes, F430L) and validated QuantiTect human primer 
sets for p62/SQSTM1 (Qiagen, QT00095676). Data collec-
tion was performed using a Chromo4 real-time PCR detector 
(BioRad) and MJ Opticon Monitor software. Expression was 
normalized relative to 18S rRNA levels (Fwd, 5'-GTA ACC 
CGT TGA ACC CCA TT-3'; Rev, 5'-CCA TCC AAT CGG 
TAG TAG CG-3').
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gel blotting was performed as previously described in reference 
28. Antibodies used for protein gel blotting were CDK11 (Rabbit 
polyclonal, Abcam ab19393), ERK2 (Ab122, CJ Marshall, 
Institute of Cancer Research, London), LC3B (Rabbit polyclonal, 
Abcam, ab48394) and p62/SQSTM1 (Mouse monoclonal, BD 
Transduction Labs; 610833). For quantification of LC3-II lev-
els, blots were visualized with fluorophore-conjugated second-
ary antibodies and detected using the Odyssey system (LI-COR 
Biosciences).
Fluorescence microscopy. Images of GFP-LC3 expressing 
cells were captured with an Olympus BX51 microscope and blind 
scored for cells that contained prominent GFP-LC3 puncta above 
background. For the screen in Drosophila cells, due to the low 
level of autophagosomes under basal conditions, a positive hit 
was when 10 autophagosomes or more where observed per cell 
(on average) following treatment with kinase RNAi.
Immunofluorescence. Cells grown on glass coverslips were 
fixed for 15 min in 4% (w/v) para-formaldehyde (PFA)/PBS and 
then permeabilized for 15 min in 0.3% (v/v) Triton X-100/PBS. 
After fixation and permeabilization, cells were washed three times 
in PBS and then blocked with 0.3% (w/v) Avid BSA (Sigma), 10% 
(v/v) FCS, 5% (w/v) nonfat milk in 0.3% (v/v/) Triton X-100/
PBS for 1 h. Cells were incubated with mouse anti-LAMP2 (BD 
PharMingen, 555803) for 60 min, followed by three washes with 
PBS and a 30 min incubation with goat anti-mouse AlexaFluor 
488 secondary antibody (Invitrogen, A11001). Coverslips were 
mounted in Dako fluorescent mounting medium (S3023) and 
visualized using a Zeiss LSM710 confocal microscope.
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